GE HealthCare Technologies Inc. (GEHC)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 2,625,000 2,513,000 2,454,000 2,416,000 2,435,000 2,523,000
Long-term debt US$ in thousands 7,449,000 9,306,000 8,233,000 8,247,000 8,436,000 10,253,000
Total stockholders’ equity US$ in thousands 8,446,000 8,317,000 7,801,000 7,408,000 7,133,000 7,131,000
Return on total capital 16.51% 14.26% 15.30% 15.43% 15.64% 14.51%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $2,625,000K ÷ ($7,449,000K + $8,446,000K)
= 16.51%

Based on the provided data, the Return on Total Capital (ROTC) for GE HealthCare Technologies Inc. has shown some fluctuation over the period from September 2023 to December 2024.

The ROTC was 14.51% in September 2023 and increased to 15.64% by December 2023, indicating an improvement in the company's ability to generate returns from the total capital employed in its operations.

However, there was a slight decline in ROTC to 15.43% in March 2024 followed by a further decrease to 15.30% in June 2024. This suggests some variability in the company's efficiency in utilizing its total capital to generate profits during these periods.

Subsequently, in September 2024, the ROTC decreased to 14.26%, showing a decline in the company's profitability relative to its total capital.

The last reported ROTC figure in December 2024 rebounded to 16.51%, indicating a significant improvement in the company's return on total capital.

Overall, GE HealthCare Technologies Inc.'s ROTC has displayed fluctuations over the given period, with some quarters showing improvements while others experiencing declines. It is essential for the company to monitor and analyze these trends to ensure sustained profitability and efficient use of its total capital resources.


Peer comparison

Dec 31, 2024

Company name
Symbol
Return on total capital
GE HealthCare Technologies Inc.
GEHC
16.51%
Hologic Inc
HOLX
12.94%